Keywords
Epidemiology
Amazonas
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the outcome of cases of American Cutaneous Leishmaniasis (ACL) and the epidemiological profile of patients diagnosed in endemic municipalities of Amazonas between 2019 and 2024. Methods: A quantitative, retrospective epidemiological study was conducted using data from the Notifiable Diseases Information System (SINAN). Individuals diagnosed with ACL in the municipalities of Manaus, Presidente Figueiredo, Itacoatiara, Rio Preto da Eva, Iranduba, and Manacapuru were included. The variables analyzed were sex, year of notification, type of entry, clinical form, and clinical evolution, with descriptive data analysis performed. Results: A predominance of male patients, of mixed race, and aged between 20 and 59 years was observed. The cutaneous clinical form was the most frequent, as were new cases and clinical evolution to cure. Conclusion: American cutaneous leishmaniasis (ACL) remains an important public health problem in endemic municipalities of Amazonas, mainly affecting individuals of working age. The predominance of cures demonstrates the relevance of early diagnosis and the assistance offered by health services, reinforcing the need to strengthen surveillance, prevention, and control actions for the disease in the region.
References
ALMEIDA IJS, et al. Pandemia pelo coronavírus à luz de teorias de enfermagem. Revista Brasileira de Enfermagem, 2020; 73(Supl. 2): e20200538.
ALMEIDA RP, et al. Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials. The American Journal of Tropical Medicine and Hygiene, 2005; 73(1): 79-81.
ALMEIDA VP, et al. A leishmaniose tegumentar americana no estado do Pará. Revista Eletrônica Acervo Saúde, 2025; 25(6): e20581.
ANVERSA L, TIBURCIO MGS, RICHINI-PEREIRA VB e RAMIREZ LE. Human leishmaniasis in Brazil: a general review. Revista da Associação Médica Brasileira, 2018; 64(3): 281-289.
BRASIL. Ministério da Saúde. Manual de Vigilância da Leishmaniose Tegumentar Americana. 2. ed. Brasília: Ministério da Saúde, 2017.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual de Orientação para a Vigilância e Cuidado da Leishmaniose Tegumentar Americana (LTA). Brasília: Ministério da Saúde, 2022.
BRASIL. Ministério da Saúde. Sistema de Informação de Agravos de Notificação – SINAN: casos de Leishmaniose Tegumentar Americana, Brasil, 2024. Brasília: Ministério da Saúde, 2024.
DIAS LC, et al. Doenças tropicais negligenciadas: uma nova era de desafios e oportunidades. Química Nova, 2013; 36(10): 1552-1556.
FROTA MMC, et al. Persistência da leishmaniose tegumentar americana no Brasil: análise de tendências temporais e padrões espaciais. Hygeia - Revista Brasileira de Geografia Médica e da Saúde, 2025; 21: e2146.
GIMBLET C, et al. Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation. Cell Host & Microbe, 2017; 22(1): 13-24.e4.
GOLLOB KJ, et al. Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunology, 2014; 36(8): 367-376.
LAINSON R, SHAW JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, editors. The Leishmaniases in Biology and Medicine. Vol. 1. Biology and Epidemiology. London: Academic Press, 1987; p. 1-120.
LEPORE CS, et al. Leishmaniose tegumentar americana: perfil epidemiológico no estado de São Paulo. Brazilian Journal of Global Health, 2024; 4(16): 1-4.
LESSA MM, et al. Mucosal leishmaniasis: epidemiological and clinical aspects. Brazilian Journal of Otorhinolaryngology, 2007; 73(6): 843-847.
REGO JRBO, et al. Leishmaniose tegumentar americana: características epidemiológicas dos últimos 10 anos de notificação. Brazilian Journal of Implantology and Health Sciences, 2023; 5(3): 1750-1765.
SALARI S, et al. Global distribution of treatment resistance gene markers for leishmaniasis. Journal of Clinical Laboratory Analysis, 2022; 36(8): 1-16.
SCORZA B, et al. Cutaneous Manifestations of Human and Murine Leishmaniasis. International Journal of Molecular Sciences, 2017; 18(6): 1-26.
SILVA JA, et al. Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium. PLOS Neglected Tropical Diseases, 2022; 16(6): 1-19.
VIANA MB, et al. Perfil epidemiológico da leishmaniose tegumentar americana no Estado do Pará, com ênfase na região do baixo Amazonas. Revista Eletrônica Acervo Saúde, 2024; 24(11): e16818.
VIEIRA CG, et al. Perfil epidemiológico da leishmaniose tegumentar americana no estado da Bahia, Brasil, 2015-2025. Periódicos Brasil: Pesquisa Científica, 2026; 5(1): 2686-2704.